Overview

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety and efficacy of 0.03% tacrolimus ointment as long-term treatment in paediatric patients with atopic dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Tacrolimus